+ Watch GILD
on My Watchlist
A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.
With more and more HIV generics around the corner it's not surprising why the CEO is selling and selling quick. Anyone actually see the retail prices on their drugs? Good God Viread is like $12 a pill. This is a friendly reminder to wear a condom. Hey, I think this company has great innovation and cash flow, but their eggs are all in one basket.
I know this pitch is outdated, but scoffing at $12 a pill? The new Hep C drug (oral treatment) costs $28,000 for the first four weeks. As for "eggs in one basket", the company has several treatments aimed at things other than HIV. If considering shorting the company, I wouldn't use this post as my rationale.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions